Asthmatin/Asthmatin 4 Indications/Uses

Asthmatin: The prophylaxis and chronic treatment of asthma; the relief of symptoms of allergic rhinitis (seasonal allergic rhinitis and perennial allergic rhinitis) in adults and adolescents 15 years of age and older.
Asthmatin 4: Montelukast is indicated in the treatment of asthma as add-on therapy in those 2 to 5 year old patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom ''as-needed" short-acting β-agonists provide inadequate clinical control of asthma.
Montelukast may also be an alternative treatment option to low-dose inhaled corticosteroids for 2 to 5 year old patients with mild persistent asthma who do not have a recent history of serious asthma attacks that required oral corticosteroid use, and who have demonstrated that they are not capable of using inhaled corticosteroids.
Montelukast is also indicated in the prophylaxis of asthma from 2 years of age and older in which the predominant component is exercise-induced bronchoconstriction.